CIEVSO Trademark

Trademark Overview


On Tuesday, August 16, 2005, a trademark application was filed for CIEVSO with the United States Patent and Trademark Office. The USPTO has given the CIEVSO trademark a serial number of 78693714. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Thursday, January 12, 2006. This trademark is owned by Pfizer Inc.. The CIEVSO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, and hemolytic diseases and disorders, pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations
cievso

General Information


Serial Number78693714
Word MarkCIEVSO
Filing DateTuesday, August 16, 2005
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateThursday, January 12, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2006

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, and hemolytic diseases and disorders, pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, January 12, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Thursday, January 12, 2006ABANDONMENT - AFTER PUBLICATION
Tuesday, January 10, 2006PUBLISHED FOR OPPOSITION
Wednesday, December 21, 2005NOTICE OF PUBLICATION
Monday, December 19, 2005TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, November 22, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 18, 2005ASSIGNED TO LIE
Thursday, November 17, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 20, 2005ASSIGNED TO EXAMINER
Wednesday, August 24, 2005NEW APPLICATION ENTERED IN TRAM